Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases and 66% overall effective by trial data
[ad_1] Another COVID-19 vaccine is almost ready to begin distribution – a single injection inoculation performed by the Janssen Pharmaceuticals subsidiary of Johnson & Johnson. The company just released an efficacy report based on data from its Phase 3 trial, which found the new vaccine to be 66% effective overall in preventing moderate to severe … Read more